PNT 5.72 Point Biopharma plummeted after the company announced exclusive license agreements with Lantheus Holdings [LNTH +1.3%] for its PNT2002 and PNT2003 therapies. LNTH 56.94 close interesting?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.